Drug Type Small molecule drug |
Synonyms LACI, TFPI, Tifacogin (USAN/INN) + [3] |
Target |
Mechanism F10 inhibitors(Coagulation factor X inhibitors), TFPI inhibitors(Tissue factor pathway inhibitor inhibitors), factor VII inhibitors(Coagulation factor VII inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Community Acquired Pneumonia | Phase 2 | PE | 01 May 2004 | |
Community Acquired Pneumonia | Phase 2 | US | 01 May 2004 | |
Community Acquired Pneumonia | Phase 2 | ES | 01 May 2004 | |
Community Acquired Pneumonia | Phase 2 | CA | 01 May 2004 | |
Community Acquired Pneumonia | Phase 2 | GB | 01 May 2004 | |
Community Acquired Pneumonia | Phase 1 | DE | 01 May 2004 | |
Community Acquired Pneumonia | Phase 1 | KR | 01 May 2004 | |
Community Acquired Pneumonia | Phase 1 | BE | 01 May 2004 | |
Sepsis | Preclinical | US | 31 Mar 2000 | |
Community Acquired Pneumonia | Discovery | BR | 01 May 2004 |